Press Releases

All Releases
View Summary Myriad Genetics Sets Record and Distribution Dates for Spin-Off of Myriad Pharmaceuticals
Jun 4, 2009
PDF 13.2 KB Add to Briefcase
View Summary Myriad Genetics to Present at The Goldman Sachs 30th Annual Global Healthcare Conference and The 8th Annual Needham Life Sciences Conference
May 28, 2009
PDF 9.4 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2009 Third Quarter Financial Results
May 4, 2009
PDF 16.9 KB Add to Briefcase
View Summary New Study Published in CANCER Supports Use of BRACAnalysis Testing Across Broad Ethnic Populations
Apr 30, 2009
PDF 13.0 KB Add to Briefcase
View Summary Myriad Genetics to Present at Bank of America and Merrill Lynch 2009 Health Care Conference and the Eighth Annual JMP Securities Research Conference
Apr 28, 2009
PDF 10.4 KB Add to Briefcase
View Summary Myriad Genetics Launches OnDose, Its Seventh Molecular Diagnostic Product
Apr 27, 2009
PDF 13.8 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2009 Third Quarter Financial Results on May 4
Apr 15, 2009
PDF 8.5 KB Add to Briefcase
View Summary Myriad Pharmaceuticals Receives IND Approval for New Cancer Drug
Apr 8, 2009
PDF 13.8 KB Add to Briefcase
View Summary Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Mar 24, 2009
PDF 12.6 KB Add to Briefcase
View Summary Myriad Genetics to Present at Citi's 4th Annual Biotech Day on April 1, 2009
Mar 23, 2009
PDF 9.8 KB Add to Briefcase
View Summary Myriad Genetics to Present at Cowen Health Care Conference on March 17, 2009
Mar 3, 2009
PDF 10.7 KB Add to Briefcase
View Summary Myriad Genetics Announces 2-for-1 Stock Split
Feb 24, 2009
PDF 11.5 KB Add to Briefcase
View Summary Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
Feb 3, 2009
PDF 15.8 KB Add to Briefcase
View Summary Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat
Jan 21, 2009
PDF 10.0 KB Add to Briefcase
View Summary Myriad Genetics Announces Second Quarter Fiscal 2009 Financial Results Conference Call
Jan 16, 2009
PDF 7.2 KB Add to Briefcase
View Summary Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
Dec 22, 2008
PDF 13.1 KB Add to Briefcase
View Summary Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing
Dec 16, 2008
PDF 10.2 KB Add to Briefcase
View Summary Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2009
Nov 4, 2008
PDF 15.3 KB Add to Briefcase
View Summary Myriad Genetics Announces First Quarter Fiscal 2009 Financial Results Conference Call
Oct 23, 2008
PDF 8.4 KB Add to Briefcase
View Summary Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies
Oct 20, 2008
PDF 13.1 KB Add to Briefcase
Showing 181-200 of 293 Page: 1 ... 6 7 8 9 10 11 12 13 14 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
38.75
Change:
+ 0.64
Open:
38.12
Previous Close:
38.11
Day High:
38.93
Day Low:
36.82
52 Week High:
42.50
52 Week Low:
20.02
Volume:
1,504,400
4:00 PM ET on Apr 15, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com